Skip to content

Investigating the effect of Buteyko Breathing technique in Lung Cancer

Investigating the effect of Buteyko Breathing technique on Respiratory function, Pain Management, and Perceived Stress in Lung Cancer Patients Undergoing Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250811066818N1
Enrollment
40
Registered
2025-10-27
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of Buteyko breathing technique on lung cancer.

Interventions

Intervention 1: Intervention group:The intervention group will receive training in the Buteyko breathing technique by the principal investigator. The training will be conducted over four weeks, with t
however, if moderate discomfort occurs, participants may inhale. Afterward, they breathe normally for at least 10 seconds. These steps are repeated several times. Intervention 2: Control group: The co

Sponsors

Zabol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: The minimum age is 20 years and the maximum age is 60 years. Patients with preserved visual and auditory functions. Patients with no prior participation in respiratory training. Patients expressing willingness to receive Buteyko breathing training. Patients with full orientation to time and place. All participants must have undergone at least two chemotherapy sessions prior to enrollment in the study. Their cancer must have been confirmed by a pathologist. Participants must not have any other chronic illnesses. No history of admission to intensive care units or end-stage disease. Participants must be able to understand the Persian language (as the researcher will provide the training in Persian). Patients must be in stage 1, 2, or 3 of lung cancer. Lung cancer must be primary (not metastatic from other organs).

Exclusion criteria

Exclusion criteria: Individuals who have received analgesic or opioid medication within four hours prior to the intervention. Patients admitted to intensive care units. Patients whose cancer has metastasized to other organs. A history of pulmonary disease or previous lung cancer. Having a history of substance abuse. Being in the disease relapse stage.

Design outcomes

Primary

MeasureTime frame
Perceived stress score, measured using the Perceived Stress Scale (PSS) developed by Cohen et al. Timepoint: Perceived stress will be measured at baseline (prior to the intervention) and four weeks after the initiation of the Buteyko breathing technique. Method of measurement: Cohen et al.'s Perceived Stress Questionnaire.;Pain management score. Timepoint: At the beginning of each session, prior to the exercises, and at the end of each session. Method of measurement: Milzak Visual Analogue Pain Scale.;Respiratory function score. Timepoint: At the beginning of each session, prior to the exercises, and at the end of each session. Method of measurement: Breathing function test.

Secondary

MeasureTime frame
Pain management score. Timepoint: At the beginning of each session, prior to the exercises, and at the end of each session. Method of measurement: Milzak Visual Analogue Pain Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hasani

Zabol University of Medical Sciences

hasanimaryam874@gmail.com+98 54 3222 3947

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026